Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CORRECTED-GLOBAL MARKETS-Stocks keep spirits up before Fed meets

Tue, 16th Mar 2021 10:04

(Corrects U.S. 10-year Treasury yield to 1.6004%)

* Graphic: Global asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates http://tmsnrt.rs/2egbfVh

By Ritvik Carvalho

LONDON, March 16 (Reuters) - World stocks rose on Tuesday,
as investors anticipated the U.S. Federal Reserve and other
central banks meeting this week will keep policies accommodative
to help drive a post-pandemic global economic recovery.

European shares extended a rally that began on Wall Street
on Monday and continued into Asia, with the pan-region STOXX 600
index up 0.5%. On Monday, the index touched
its highest level in more than a year before ending flat.

Britain's FTSE 100 index rose 0.7%, Germany's DAX
0.6%, France's CAC 40 0.2% and Italy's FTSE MIB index
0.6%.

E-mini futures for the S&P 500 hit a record high
before trading flat on the day.

MSCI's All Country World Index, which tracks stocks across
49 countries, rose 0.2% to its highest levels since Feb 25.

An index of Asia-Pacific share markets excluding Japan
gained 0.65%, led by a 0.8% jump in Australia's
benchmark S&P/ASX 200 index.

Japan's Nikkei 225 gained 0.5% to just below the
30,000 mark. The broader Topix added 0.65%.

China's blue-chip CSI 300 index climbed 0.87% and
Hong Kong's Hang Seng gained 0.67%.

"The stock markets have kept their spirits up ahead of
tomorrow's important Fed announcement," said Karl Steiner, chief
quantitative strategist at SEB.

On Monday, the S&P 500 and Dow Jones Industrial Average both
soared on gains in travel stocks as mass vaccinations in the
United States and congressional approval of a $1.9 trillion aid
bill fueled investor optimism.

Longer-term U.S. Treasury yields slipped further on
Tuesday, as the market looked ahead to government debt auctions
and the Fed's two-day policy meeting, which will conclude on
Wednesday.

The benchmark 10-year yield, which reached a
more than one-year high of 1.642% last week, was back at
1.6004%.

The earlier surge in yields stemmed from investors
speculating that rising inflation expectations could prompt the
Federal Open Market Committee to signal it will start raising
rates sooner than expected.

"We think the FOMC will have a hard time expressing concern
about asset markets with the S&P at an all-time high on 12
March, despite 10Y U.S. Treasury yields at post-February 2020
highs," said analysts Steve Englander and John Davies at
Standard Chartered.

"Focus has been on the FOMC ‘dot plot’ in recent days, but
if the FOMC and Fed Chair (Jerome) Powell do not push back
against current yield levels, investors are likely to take
yields higher as better data arrives."

Fed policymakers are expected to forecast that the U.S.
economy will grow in 2021 by the fastest rate in decades, as it
recovers from a coronavirus-stricken 2020.

The Bank of England also meets this week on Thursday and the
Bank of Japan wraps up a two-day meeting on Friday.

On Wall Street, the Dow Jones Industrial Average rose
174.82 points, or 0.53%, to 32,953.46, the S&P 500 gained
25.6 points, or 0.65%, to 3,968.94 and the Nasdaq Composite
remained unchanged.

Airline shares rose as the companies pointed to
concrete signs of an industry recovery as vaccine rollouts help
spur leisure bookings.

The outlook for post-pandemic recoveries continued to
diverge between the U.S. and Europe.

President Joe Biden's order to make vaccination available to
all adults by May 1 contrasted with stuttering rollouts in
Germany, France and elsewhere, where use of the AstraZeneca
vaccine has been suspended amid concern over possible
side effects.

However, Kyle Rodda, an analyst at IG Markets, said the
prospect of a slower economic recovery in Europe didn't appear
to be a major handicap for investors.

"It doesn't seem to be the view that this is a real risk,"
he said. "Investors are wary, but not worried."

In currencies, the U.S. dollar held small gains from
overnight, with caution evident ahead of the central bank
meetings.

The dollar was largely flat at 109.19 yen, after
rising as high as 109.365 on Monday for the first time since
June.

The euro was little changed at $1.1930, holding for
an eighth session below the $1.20 level.

Bitcoin halted its slide from a record high of
$61,781.83 reached on Saturday, last trading 1% higher on the
day around $56,250.

U.S. West Texas Intermediate crude for April changed
hands at $64.74 a barrel, down 1%. Brent crude futures
for May stood at $68.22 a barrel, losing 1%.

(Reporting by Ritvik Carvalho; additional reporting by Kevin
Buckland and Kane Wu in Tokyo; editing by Larry King)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.